Zephyrnet Logo

Tag: Type 2 diabetes

ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call | BioSpace

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced today...

Top News

Ciba Health Raises $10M for its Integrated Care Platform for Chronic Conditions

Nearly 60% of adult Americans have at least one chronic condition with a total cost of $3.7T per year. Rising levels of chronic diseases...

The Mediterranean Diet

My recent holiday to Turkey got me thinking about the British (and ‘western’) diet and just how bad it is for our health and...

Klick Health Creates Generative AI Tool to Eliminate Common Advertising Agency Groundhog Day Scenarios

Genome Perspective provides an innovative human/AI hybrid solution to rapidly accelerate project brief creation and bypass mundane, repetitive aspects of the process TORONTO & NEW...

Anti-Pot Karens Rise Up in New York – Scott Gray (R-NY) Wants Cannabis Billboards Banned Because He Didn’t Like a ‘Got Weed’ Ad

Cannabis faces such strong social disapproval in New York that some residents prefer not to encounter it at all. To eliminate the visibility of...

Protect Yourself with Specialized Diabetes Insurance! – Supply Chain Game Changer™

Do you need a specialized diabetes insurance plan? Or are you eligible for regular term insurance or any other life insurance policy? The latter...

Diets, Weight loss and the Environment

A guest blog by Wise OutReach on diets, weight loss and the environment. Once upon a time, a diet was simply about losing weight....

Weederall? The Sports Car of Cannabis? – Why Rare THCV Cannabis Strains Are All the Rage Right Now in California

In 1970, a groundbreaking discovery unfolded within the hallowed halls of the University of Oxford as researchers delving into cannabis stumbled upon a chemical...

Obesity drug success sparks biotech buying spree

The last few months have seen the obesity drug market soar, after new weight loss and diabetes drugs like Novo Nordisk’s Wegovy and Ozempic...

Novo Nordisk, Evotec partner in metabolic disease drug discovery pact

Novo Nordisk is deepening its investment in cardiometabolic disease drug development, this time with a partnership with German biotech Evotec. The companies announced Tuesday a new...

US FDA Approves Jardiance for the Treatment of Adults with Chronic Kidney Disease

RIDGEFIELD, Conn. and INDIANAPOLIS, Sept. 22, 2023 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Jardiance® (empagliflozin) 10 mg tablets to...

Intarcia’s Diabetes Drug-Device Implant Unanimously Rejected by Adcomm | BioSpace

Pictured: People in suits with their thumbs down/iStock, iammotos The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee on Thursday unanimously voted against Intarcia Therapeutics’...

Understanding PCOS: Symptoms, Risks, and Awareness – Seattle Clinical Research Center

September is Polycystic Ovary Syndrome (PCOS) Awareness Month, dedicated to spreading knowledge on this common yet often misunderstood health condition. PCOS affects millions of...

Latest Intelligence

spot_img
spot_img